Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | AZN | AMGN | GILD | BMY |
| Company | Biogen Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 168.87 | 94.47 | 328.70 | 123.80 | 56.46 |
| High | 169.34 | 94.52 | 332.33 | 125.07 | 56.56 |
| Low | 164.25 | 93.51 | 326.90 | 122.10 | 55.37 |
| Latest | 164.67 | 94.28 | 332.93 | 124.56 | 55.59 |
| Change | -3.90 | +0.29 | +2.90 | +3.30 | -1.03 |
| % Change | -2.31% | +0.31% | +0.88% | +2.72% | -1.82% |
| Volume | 873,467 | 5,703,874 | 1,517,338 | 3,100,128 | 6,115,825 |
| 20-Day Average Volume | 2,171,933 | 5,372,835 | 2,620,038 | 6,018,247 | 13,898,614 |
| Previous Close | 168.57 | 93.99 | 330.03 | 121.26 | 56.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 176.93 | 93.11 | 329.17 | 122.87 | 54.91 |
| 20-Day Raw Stochastic | 0.08% | 66.05% | 51.59% | 67.00% | 67.37% |
| 20-Day Relative Strength | 41.17 | 57.08 | 53.13 | 52.48 | 59.77 |
| Weighted Alpha | +20.96 | +43.88 | +22.39 | +30.80 | +7.04 |
| Today's Opinion | 56% Buy | 100% Buy | 80% Buy | 72% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 80% Buy | 100% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.38% since 01/09/26 | -0.54% since 01/09/26 | +1.51% since 01/09/26 | +2.34% since 01/09/26 | -0.80% since 01/09/26 |
| Low | 164.37 on 01/16/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 55.33 on 01/15/26 |
| High | 188.00 on 01/12/26 | 96.43 on 01/14/26 | 332.50 on 01/15/26 | 125.07 on 01/16/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | -4.15% since 12/16/25 | +3.05% since 12/16/25 | +1.31% since 12/16/25 | +4.34% since 12/16/25 | +2.19% since 12/16/25 |
| Low | 164.37 on 01/16/26 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 190.20 on 01/09/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | +15.56% since 10/16/25 | +12.30% since 10/16/25 | +11.90% since 10/16/25 | +5.16% since 10/16/25 | +27.71% since 10/16/25 |
| Low | 138.00 on 10/30/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 190.20 on 01/09/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | +27.97% since 07/16/25 | +34.33% since 07/16/25 | +10.70% since 07/16/25 | +12.82% since 07/16/25 | +17.48% since 07/16/25 |
| Low | 121.05 on 07/21/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 190.20 on 01/09/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 24,729,558 | 291,505,472 | 177,714,880 | 150,444,864 | 115,264,336 |
| Shares Outstanding, K | 146,702 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 9,675,900,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | 1,632,200,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 2,534,700,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | 466,500,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.13 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 4.81 on 10/30/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 02/11/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 10.11 | 21.08 | 15.04 | 15.15 | 8.69 |